GlassScriptPhysician profile
Matthew Thomas Sugalski
NPI 1487657169
$1,511.95
in general payments reported to CMS, 2019-2025
19 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2021: $221 · 2022: $661 · 2023: $100 · 2024: $104 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $492.41 | 2021-2022 | |
| Orthofix Medical, INC. | $165.91 | 2022 | |
| Bioventus LLC | $146.87 | 2022 | |
| Avanos Medical | $137.71 | 2019 | |
| Smith+Nephew, INC. | $113.93 | 2019 | |
| Electronic Waveform Lab, INC. | $100.48 | 2023 | |
| Intrinsic Therapeutics | $66.77 | 2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic, INC. | $39.52 | 2024 | Intellis Adaptivestim |
| Ossur Americas, INC. | $37.26 | 2025 | |
| Organogenesis INC. | $34.29 | 2021 | |
| Djo, LLC | $27.77 | 2024 | Cmf |
| Innovation Technologies INC | $24.31 | 2025 | Irrisept |
| Kerecis Limited | $23.24 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acumed LLC | $22.49 | 2025 | Acumed |
| Zimmer Biomet Holdings, INC. | $22.31 | 2024 | Gel-One Cross-Linked Hyaluronate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.29 | 2022 | |
| Ibsa Pharma INC. | $14.03 | 2024 | Licart, Tirosint |
| Pacira Therapeutics, INC. | $13.88 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sugalski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.